News

Geron Corp. quits stem cell work

 

The Menlo Park-based biotechnology firm Geron Corp. announced recently that it was abandoning its stem cell research in favor of focusing on two cancer drugs.

The motivation appears financial, according to a statement issued by the company.

"The decision to narrow Geron's technology and therapeutic focus was made after a strategic review of the costs, value inflection timelines and clinical, manufacturing and regulatory complexities," the company said.

As a result, 66 jobs -- 38 percent of its workforce -- will be eliminated, the company said.

The news came as a blow to those hoping to benefit from stem cell therapy, a field that held promise for those paralyzed by spinal cord injuries.

Stem cells possess the ability to become any other type of cell in the body, leading Geron's scientists to explore how to grow the cells into replacement neurons that could reverse paralysis.

What is community worth to you?
Support local journalism.

Comments

Sorry, but further commenting on this topic has been closed.

Be the first to know

Get the latest headlines sent straight to your inbox every day.

Natural wine bar Salvaje opens in Palo Alto
By Elena Kadvany | 0 comments | 1,892 views

Cap On? Cap Off? Recycling Bottles is Confusing
By Laura Stec | 41 comments | 1,810 views

Premarital and Couples: "Our Deepest Fear" by Marianne Williamson
By Chandrama Anderson | 0 comments | 1,549 views

Everything you've always wanted to know ...
By Sherry Listgarten | 12 comments | 1,103 views

Menlo Park Planning For Civic Projects Needs A Major Reboot. (Part 1)
By Dana Hendrickson | 1 comment | 155 views